Cash Loans
  Welcome

Apply online now and you could turn this cheque into cash. With Provident you could get the money you need, when you need it, with fixed weekly repayments.

Cash straight to your door
  We could offer you a loan of up to £500 delivered direct to your door within days.

There are no complicated forms to fill in, just a friendly agent who'll deliver money to your door then call to collect your fixed weekly repayments.

It's simple and straightforward with Provident

  1. Apply online now and tell us how much you need.
  2. A friendly agent will visit your home to discuss your needs.
  3. If your loan application is accepted your agent will deliver the money to your home.
  4. Your agent will call weekly at a time to suit you to collect your repayments.
We understand that everyone needs a helping hand now and again and if you apply for a loan with us, we could help you too.

Why not get in touch today?
Apply here
  The UK's leading home credit provider - serving over 1 million customers every week

Compare the price of home collected and other cash loans available in your area at www.lenderscompared.org.uk

All home credit customers are entitled to a free detailed statement once every
3 months; just ask.

Copyright © Provident Financial Management Services Ltd 2008. Written credit quotations are available on request. Available to UK residents aged 18* and over. Applications subject to acceptance. Calls may be recorded.
Provident Personal Credit Ltd. Registered Office: Colonnade, Sunbridge Road, Bradford BD1 2LQ. Registered Number 146091 England.

Online payday loans are marketed through e-mail, online search, paid ads, and referrals. Typically, a consumer fills out an online application form or faxes a completed application that requests personal information, bank account numbers, Social Security number and employer information. Borrowers fax copies of a check, a recent bank statement, and signed paperwork. The loan is direct-deposited into the consumer's checking account and loan payment or the finance charge is electronically withdrawn on the borrower's next payday.
Cash LoansCash Loan
 








Orient Securities Shanghai Pharmaceutical Company changes the actual controller Money Tips

Data:2009-12-12 2:34

Category: Money tips Release Date: 2006-10-01

Major shareholder of the company recently received a notice from China Huayuan Group Co., Ltd. (hereinafter referred to as "Huayuan Group"), shareholders of changes is as follows: change the Huayuan Huayuan Group shareholders Asset Management Co., Ltd. (hereinafter referred to as "Huayuan Assets "), Huayuan Huayuan Group holds 100% equity stake. This change of equity issues on January 15, 2007 to obtain business financing approved by the Ministry of Commerce of the PRC.

Kim Ha-Huayuan other shareholders acquired the entire stake held by Huayuan Group, and immediately after the completion of any such shares, as well as Kim Ha-self-possession Huayuan Group Total 100% stake in all of the assets transferred to the Huayuan; of these, for the SASAC held by the Huayuan Group 9.136% of the shares will first be transferred without compensation by the SASAC for China Resources, and then the other by the China Resources share transfer payments summer. The completion of the acquisition, Huayuan Huayuan Group holds 100% equity stake.

The completion of the acquisition, China Resources assets to be adopted by Huayuan Huayuan Group, medicine, textile, and other businesses to integrate plate to completely solve the Huayuan Group, the debt crisis, the central enterprises to speed up the layout and structural adjustment, stronger and excellent Huayuan Group's pharmaceutical and textile industries, and improve Huayuan Group's overall profitability.

China Resources to speed up the process of integration of Huayuan Group, the market can infer from CRC will speed up the Huayuan Group, the assets within the scope of the integration of Chinese medicine. Resources to Shanghai Pharmaceutical market as a platform for the integration of its pharmaceutical assets, full of expectations. Therefore, the recent Shanghai Pharmaceutical's shares.

However, we believe that integration of Huayuan CRC's vision of the pharmaceutical assets of an expected slow growth and realistic results are expected in 2006 earnings per share was 0.18 yuan, we forecast 2007 net profit growth of 15%, earnings per share 0.22 yuan, the company in 2007 the dynamics of PE of 50 times, give the stock a neutral rating on the investment.

Related Articles